These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2759729)

  • 1. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione.
    Reed MJ; Owen AM; Lai LC; Coldham NG; Ghilchik MW; Shaikh NA; James VH
    Int J Cancer; 1989 Aug; 44(2):233-7. PubMed ID: 2759729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues.
    Reed MJ; Aherne GW; Ghilchik MW; Patel S; Chakraborty J
    Int J Cancer; 1991 Oct; 49(4):562-5. PubMed ID: 1917157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women.
    Purohit A; Riaz AA; Ghilchik MW; Reed MJ
    Horm Metab Res; 1992 Nov; 24(11):532-6. PubMed ID: 1452119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients.
    Jones AL; MacNeill F; Jacobs S; Lonning PE; Dowsett M; Powles TJ
    Eur J Cancer; 1992; 28A(10):1712-6. PubMed ID: 1389491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer.
    Reed MJ; Lai LC; Owen AM; Singh A; Coldham NG; Purohit A; Ghilchik MW; Shaikh NA; James VH
    Cancer Res; 1990 Jan; 50(1):193-6. PubMed ID: 2293555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of oestrogen synthesis in postmenopausal women with breast cancer.
    James VH; Reed MJ; Purohit A
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):149-53. PubMed ID: 1525057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours.
    Purohit A; Lai LC; Singh A; Coldham NG; Ghilchik MW; Reed MJ; James VH
    J Steroid Biochem; 1989; 34(1-6):443-6. PubMed ID: 2533950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of tissue oestradiol levels in human breast cancer.
    Santen RJ
    Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of aromatase in breast tumors.
    Reed MJ
    Breast Cancer Res Treat; 1994; 30(1):7-17. PubMed ID: 7949206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women.
    McNeill JM; Reed MJ; Beranek PA; Bonney RC; Ghilchik MW; Robinson DJ; James VH
    Int J Cancer; 1986 Aug; 38(2):193-6. PubMed ID: 3733259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues.
    Larionov AA; Berstein LM; Miller WR
    J Steroid Biochem Mol Biol; 2002 May; 81(1):57-64. PubMed ID: 12127042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transformation of 19-hydroxyandrostenedione to estrone and estradiol by rat embryonic testis in vitro].
    Weniger JP; Zeis A
    Reprod Nutr Dev; 1990; 30(2):253-7. PubMed ID: 2161668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy.
    Coldham NG; Lai LC; Reed MJ; Ghilchik MW; Shaikh NA; James VH
    Br J Cancer; 1990 Aug; 62(2):263-6. PubMed ID: 2143678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of aromatisation by a urine technique suitable for the evaluation of aromatase inhibitors in vivo.
    Jacobs S; Lønning PE; Haynes B; Griggs L; Dowsett M
    J Enzyme Inhib; 1991; 4(4):315-25. PubMed ID: 1669831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of the product isolation and the radiometric aromatase assays for the measurement of low levels of aromatase: lack of aromatase activity in the human endometrium.
    Prefontaine M; Shih C; Pan CC; Bhavnani BR
    J Endocrinol; 1990 Dec; 127(3):539-51. PubMed ID: 2280217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of aromatase activity in human breast tumors.
    Tilson-Mallett N; Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1125-8. PubMed ID: 6630410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment.
    Lønning PE; Dowsett M; Jones A; Ekse D; Jacobs S; McNeil F; Johannessen DC; Powles TJ
    Breast Cancer Res Treat; 1992; 23(1-2):57-62. PubMed ID: 1446052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.
    Johannessen DC; Adlercreutz H; Fotsis T; Lønning PE
    Br J Cancer; 1993 Aug; 68(2):393-8. PubMed ID: 8135918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione.
    Budnick RM; Dao TL
    Steroids; 1980 May; 35(5):533-41. PubMed ID: 7394858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.